Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery Article

fiu authors

publication date

  • January 1, 2012

keywords

  • ALPHA(V)BETA(3)
  • BRAIN-TUMORS
  • INTEGRIN
  • Integrins
  • Life Sciences & Biomedicine
  • MECHANISMS
  • Neurosciences & Neurology
  • Pharmacokinetics

Digital Object Identifier (DOI)

end page

  • 153